Introducing IVIM Technology’s first newsletter of 2026, IVIM TECHNOLOGY
NEWSLETTER
Volume 10, May 2026 |
|
|
About IVIM Technology, Inc.
Founded in 2017, IVIM Technology is a global leader in turnkey intravital microscopy solutions. Our all-in-one box confocal and two-photon microscope systems enable real-time cellular imaging in live, anesthetized animals—transforming the landscape of in vivo research.
Recognized as one of the Top 10 APAC Bioanalytical Service Providers, IVIM serves a broad network of over 100 institutions worldwide, spanning academia, biotechnology, and the pharmaceutical industry. Our integrated portfolio includes intravital microscopy (IVM) systems, preclinical in vivo imaging solutions, training, specialized accessories, and labeled antibodies—empowering researchers to drive scientific discovery with precision, consistency, and efficiency.
|
|
|
IVIM Technology’s Intravital Microscopy Contributed to 14+ High-Impact Publications in the First Half of 2026. |
|
|
IVIM Technology's remarkable technical competitiveness was validated through the publications in the world's most prestigious scientific journals. In the first half of 2026 alone, leading researchers worldwide published more than 14 high-impact peer-reviewed studies utilizing IVIM’s all-in-one intravital microscopy solutions.
Most notably, IVIM systems were officially listed as core instruments in the “Key Resources Table” of multiple high-impact journals. This recognition highlights the growing adoption of IVIM’s real-time in vivo imaging platforms in cutting-edge biomedical research.
|
|
|
< Che, Yanjia et al. (Reza Abdi Lab, BWH)), Circulation > |
|
|
Beyond these achievements, a growing number of customer success stories have continued to appear in leading biomedical journals, including Cell Metabolism, Nature Communications, and Advanced Functional Materials. By delivering high-resolution, quantitative 3D imaging data of cellular interactions in live animals, IVIM Technology has established itself as an essential imaging platform for leading laboratories pursuing high-impact scientific publications. |
|
|
Opportunity for On-site Demonstrations & Hands-on Sessions |
|
|
IVIM Technology offers on-site demos & hands-on sessions for laboratories and hospitals across the US, Europe, and Asia. If you are interested in applying our advanced in vivo imaging platform to your research, contact us to discuss how IVIM can support your research applications. |
|
|
Major IVIM Activities in Q1–Q2 2026 |
|
|
FLAIR 2026 at UC Irvine
Showcasing the Future of Real-Time Intravital Fluorescence Imaging! |
|
|
IVIM Technology participated in the AIM/LFD Workshop: FLAIR 2026 at UC Irvine, where we showcased our real-time intravital fluorescence imaging platform for advanced in vivo research. We highlighted high-resolution live-animal imaging using fluorescent antibodies, and customizable DIY imaging kits for dynamic cellular and vascular visualization. |
|
|
REGENAGE 2026 Singapore
Expanding IVIM’s APAC Presence in Ageing Research |
|
|
REGENAGE 2026 provided an opportunity to expand into ageing and regenerative medicine. Through our booth showcase and a presentation by CEO, we highlighted real-time imaging for tissue regeneration and cellular dynamics while confirming strong growth potential in the APAC research market. |
|
|
IMMUNOLOGY 2026
Strengthening IVIM’s Leadership in Immunology |
|
|
Following last year’s successful participation, IVIM returned to IMMUNOLOGY 2026, the annual meeting of the American Association of Immunologists, to further highlight our strengths in immune-focused in vivo imaging. During the three-day exhibition, IVIM connected with a wide range of immunology researchers, while our on-site workshop attracted approximately 80 attendees, reflecting strong interest in real-time visualization of immune cell dynamics and live-animal imaging applications. |
|
|
Special Joint Webinar
With a “Top 10 Papers in Cardio-Oncology 2025” Author |
|
|
We hosted a special joint webinar featuring Michał Mączewski, author of one of “The Year in Cardiovascular Medicine 2025: Top 10 Papers in Cardio-Oncology,” alongside Pilhan Kim. The webinar focused on published data demonstrating how IVIM’s motion stabilizer technology enables stable real-time intravital imaging of the beating heart in vivo for cardiovascular and cardio-oncology research. |
|
|
Exclusive First Promotion for IVIM Subscribers |
|
|
IVIM Technology not only supports academic research, but also provides specialized CRO imaging services for drug development and in vivo distribution studies. Our platform enables customized experimental design across brain, skin, and retina applications using a variety of disease models. For detailed study schemes and package pricing, explore the CRO flyer below. |
|
|
Upcoming Exhibitions in Q3 2026
- May 29-June 2 | 2026 ASCO Annual Meeting
- Jul 6-10 | FENS Forum 2026 (Federation of European Neuroscience Societies)
- Jul 30-Aug 2 | Neuro 2026
- September 6-10 | IVBM 2026 (International Vascular Biology Meeting)
- September 6-8 | K-Brain 2026 (Korean Society for Brain and Neural Sciences)
- September 10-13 | The 19th Annual Meeting of the Chinese Neuroscience Society
|
|
|
IVIM TECHNOLOGY. All Rights Reserved.
|
|
|
IVIM Technologyinformation@ivimtech.com#A-1305, Hyundai Knowledge Industry Center, 11, Beobwon-ro 11-gil, Songpa-gu, Seoul, 05836, Korea Tel: +82-2-431-7450Unsubscribe |
|
|
|
|